× ×ª×× × ×ª×¨×פ×
××רש×
| ××× ×× ×× × ×ספ××
|
|
| ק×××¦× ×¤×¨×ק×××××ת (ATC4)
|
L04AX
Other immunosuppressants
|
| ×ר××× ×¤×¢×× (ATC5)
|
Â
|
| צ×רת ×ת×
|
פ××× - PER OS
|
| צ×רת ××× ××
|
קפס××× ×§×©×××, HARD CAPSULE
××× ×עת ××× ×× ×תר ×× ×רע×× ×ש ××××× ×ת ×תר××¤× ××ת×× ×××× ×× ××××××¥ ××¤× ×©××פ××¢ ××¢××× ×צר××
|
| ×ת××××
|
Multiple Myeloma (MM)Revlimid is indicated for the treatment of multiple myeloma.Myelodysplastic Syndromes REVLIMID is indicated for patients with transfusion-dependent anemia due to low- or intermediate-1-risk myelodysplastic syndromes (MDS) associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormalities.Revlimid 7.5 mg is not indicated for treatment in MDS.Mantle Cell LymphomaREVLIMID is indicated for the treatment of adult patients with relapsed and/or refractory mantle cell lymphoma (MCL).Follicular lymphomaRevlimid in combination with rituximab (anti-CD20 antibody) is indicated for the treatment of adult patients with previously treated follicular lymphoma.
|
| × ×ª×× × ×ס×
|
ת×ר×× ××××× ×ס×
- 03/01/2010
|
×××××ת ×ס×
- תר××¤× ×××××ת ×ר×ש×× ×¢'× ×¨××¤× ××××× ×× ××××× ××רת
|
×ת×××× ×ס×
| ×ת×××× |
ת×ר×× ××××× |
ת××× ×§××× × |
Class Effect |
××¦× ×××× |
×ס×ס ×××××ת
|
| ×ש×××× ×¢× Rituximab, ×××פ×× ××××פ××× ×¤×××ק××ר×ת ××§× ××פ×× ×תק×× |
01/03/2021 |
××××××××× |
|
×××פ××× ×¤×××ק××ר×ת, Follicular lymphoma |
|
| ××××××× × ×¤××¦× ×××תק××× ××× ××××: ×. ×××× ×©××¨× ×§××× ××פ×× ×××××ª× ×××× × ×××¢×× ××שת×ת ×× ×¢×¦×. ×××פ×× ××× ×ª× ×ש×××× ×¢× Dexamethasone ×× ×ש×××× ×¢× Dexamethasone ×-Bortezomib. ×. ×××פ×× ××××§× ××××××× ××ש ×××ר ×שת×ת ×× ×¢×¦×. |
16/01/2019 |
××××××××× |
|
××××××× × ×¤×צ×, Multiple myeloma |
|
| תס××× ×ª ×××××××ספ×ס××ת ×ר×ת ××××¨× low ×× intermediate-1 ×¢× ××¤×¨×¢× ×¦××××× ××ת ×ס×× deletion 5q.
|
10/01/2012 |
××××××××× |
|
MDS, Myelodysplastic syndrome |
|
×. ×תר××¤× ×××××¨× ×ª×× ×ª× ×××פ×× ×××××××× × ×¤××¦× ××××× ×©××××ª× ×¢×××× ×× × ×©× ×ת ×××ר ××צ×× ×§× ××פ×× ××× ×©××× ××× ×××©× ××× â Bortezomib ×× Thalidomide, ××× ×× ××××× ××××ª× ××ר×ת × ×× ×××× ××××פ×××× ××××ר××.
×. ×¢× ××£ ××××ר ×פסקת ××©× × × ×××פ×× ×ת×ש×ר ××פסק:
1. ××××× ×©××××ª× ×תק×× ×××ר ×©× × ×××××¨× ××פ×× ××××× ×× ×ר××¢× ×××××¨× ××פ×× ××ק×××.
2. ×××× ×©×¤××ª× ×ª×פע×ת ××××× ×§×©×ת ×××פ××.
×. ×××פ×× ×ת×ש×ר ××× ×ª× ××××× ×©××¨× ×××¤× ×-Lenalidomide ××××× ××. |
23/01/2011 |
××××××××× |
|
××××××× × ×¤×צ×, Multiple myeloma |
|
×. ×תר××¤× ×××××¨× ×ª×× ×ª× ×××פ×× ×××××××× × ×¤××¦× ××××× ×©××××ª× ×¢×××× ×× × ×©× ×ת ×××ר ×פ××ת ×©× × ×§××× ××פ×× ×©×××× BORTEZOMIB ×-THALIDOMIDE, ××× ×× ××××× ××××ª× ××ר×ת × ×× ×××× ××××פ×××× ××××ר××.
×. ×¢× ××£ ××××ר ×פסקת ××©× × (×) ×××פ×× ×ת×ש×ר ××פסק:
1. ××××× ×©××××ª× ×תק××× ×××ר ×©× × ×××××¨× ××פ×× ××××× ×× ×ר××¢× ×××××¨× ××פ×× ××ק×××.
2. ×××× ×©×¤××ª× ×ª×פע×ת ××××× ×§×©×ת ×××פ××.
×. ×××פ×× ×ת×ש×ר ××× ×ª× ××××× ×©××¨× ×××¤× ×-LENALIDOMIDE ××××× ××. |
03/01/2010 |
××××××××× |
|
××××××× × ×¤×צ×, Multiple myeloma |
|
|
ש×××ש ×ס×
-
|
×ס×רת ××××× ×ס×
- ×. ×תר××¤× ×××××¨× ×ª×× ×ª× ×××פ×× ××קר×× ××××:
- 1. ××××××× × ×¤××¦× ×××תק××× ××× ××××:
- ×. ×××× ×©××¨× ×§××× ××פ×× ×××××ª× ×××× × ×××¢×× ××שת×ת ×× ×¢×¦×.×××פ×× ××× ×ª× ×ש×××× ×¢× Dexamethasone ×× ×ש×××× ×¢× Dexamethasone ×-Bortezomib.
- ×. ××× ×תרפ×× ×××פ×× ××××§× ××××××× ××ש ×××ר ×שת×ת ×× ×¢×¦×.
- ×. ×××× ×©××××ª× ×¢×××× ×× × ×©× ×ת ×××ר ××צ×× ×§× ××פ×× ××× ×©××× ××× ×××©× ××× - BORTEZOMIB ×× THALIDOMIDE, ××× ×× ×× ××××× ××××ª× ××ר×ת × ×× ×××× ××××פ×××× ××××ר××. ×¢× ××£ ××××ר ××¤×¡×§× ×× ×××פ×× ×ת×ש×ר ××פסק ××××× ××¢×× × ×¢× ××× ××××:
- ×. ××××× ×©××××ª× ×תק××× ×××ר ×©× × ×××××¨× ××פ×× ××××× ×× ×ר××¢× ×××××¨× ××פ×× ××ק×××.
- ×. ×××× ×©×¤××ª× ×ª×פע×ת ××××× ×§×©×ת ×××פ××. ×××פ×× ×ת×ש×ר ××× ×ª× ××××× ×©××¨× ×××¤× ×-Lenalidomide ××××× ××.
- 2. תס××× ×ª ×××××××ספ×ס××ת ×ר×ת ××××¨× low ×× intermediate-1 ×¢× ××¤×¨×¢× ×¦××××× ××ת ×ס×× deletion 5q.
- 3. ×ש×××× ×¢× Rituximab, ×××פ×× ××××פ××× ×¤×××ק××ר×ת ××§× ××פ×× ×תק××.
- ×. ××ª× ×תר××¤× ×××××¨× ×××¢×©× ××¤× ××¨×©× ×©× ××××× ××××××××××.
|
|
| ×ת××ת ××× ××
|
Posology and method of administration
|
| ×ת××××ת × ××
|
Contraindications
|
| ת×פע×ת ×××××
|
Undesirable effects
|
| ת××××ת ××× ×ª×¨×פת××ת
|
Interaction with other medicinal products and other forms of interaction
|
| ש×××ש ×××ר××× ××× ×§×
|
Pregnancy and Lactation
|
| פר×ק×××× ××ק×
|
Pharmacodynamic Properties
|
| פר×ק×ק×× ××ק×
|
Pharmacokinetic Properties
|
| ×¢××× ×ר××¤× ××××ר×ת ××¢×××
|
Â
Â
|
ת×ר×× ×¢××××: 18/08/2024
CELGENE
ר×××××× - Revlimid
true
השינוי האחרון נעשה בֹ־30 באוגוסט 2024 ב־02:18
